Physician profile
Eugene A Coman
NPI 1497713887
$1,361.66
in general payments reported to CMS, 2019-2025
20 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $18.97 · 2023: $114 · 2024: $414 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $229.56 | 2019-2025 | Skyrizi, Rinvoq |
| Genzyme Corporation | $163.04 | 2023-2025 | |
| Boston Scientific Corporation | $155.94 | 2025 | Axios |
| Pfizer INC. | $129.52 | 2019-2025 | |
| Janssen Biotech, INC. | $112.28 | 2019-2025 | Stelara, Tremfya, Simponi |
| Madrigal Pharmaceuticals | $105.91 | 2024-2025 | Rezdiffra, Resmetirom |
| Phathom Pharmaceuticals, INC. | $96.35 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $89.22 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Ardelyx, INC. | $43.81 | 2024-2025 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $36.86 | 2019 | |
| Celgene Corporation | $30.80 | 2023 | Zeposia |
| Lilly USA, LLC | $28.08 | 2025 | Omvoh |
| Shire North American Group INC | $23.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.73 | 2019 | |
| Braintree Laboratories, INC. | $20.79 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Capsovision, INC. | $18.13 | 2024 | Capsocam Plus |
| Shionogi INC | $14.50 | 2019 | |
| Olympus America INC. | $13.97 | 2024 | Evis X1 Video System Center |
| Allergan, INC. | $13.45 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Coman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.